End points | A (n=45) n (%) | B (n=155) n (%) | p Value | Relative risk | |
---|---|---|---|---|---|
Estimate | 95% CI | ||||
Death, reinfarction, repeat revascularisation of the culprit artery, cardiogenic shock, CHF | |||||
At 30 days | 5 (11.1) | 6 (3.9) | 0.07 | 2.87 | 0.92 to 8.97 |
At 3 months | 6 (13.3) | 9 (5.8) | 0.10 | 2.30 | 0.86 to 6.11 |
At 6 months | 6 (13.3) | 11 (7.1) | 0.19 | 1.88 | 0.74 to 4.80 |
At 1 year | 6 (13.3) | 14 (9.0) | 0.40 | 1.48 | 0.60 to 3.62 |
Efficacy end point—death | |||||
At 30 days | 3 (6.7) | 2 (1.3) | 0.07 | 5.17 | 0.89 to 29.98 |
At 3 months | 4 (8.9) | 4 (2.6) | 0.07 | 3.44 | 0.90 to 13.23 |
At 6 months | 4 (8.9) | 5 (3.2) | 0.12 | 2.76 | 0.77 to 9.83 |
At 1 year | 4 (8.9) | 7 (4.5) | 0.26 | 1.97 | 0.60 to 6.42 |
Efficacy end point—death/reinfarction | |||||
At 30 days | 3 (6.7) | 5 (3.2) | 0.31 | 2.07 | 0.51 to 8.32 |
At 3 months | 4 (8.9) | 7 (4.5) | 0.26 | 1.97 | 0.60 to 6.42 |
At 6 months | 4 (8.9) | 8 (5.2) | 0.36 | 1.72 | 0.54 to 5.46 |
At 1 year | 4 (8.9) | 10 (6.4) | 0.57 | 1.38 | 0.45 to 4.18 |
CHF, congestive heart failure.